4//SEC Filing
MUEHL DANIEL W 4
Accession 0000899243-22-016299
CIK 0001466301other
Filed
May 2, 8:00 PM ET
Accepted
May 3, 4:15 PM ET
Size
15.2 KB
Accession
0000899243-22-016299
Insider Transaction Report
Form 4
MUEHL DANIEL W
See Remarks
Transactions
- Exercise/Conversion
Restricted Stock Units
2022-05-01−4,625→ 32,375 total→ Common Stock (4,625 underlying) - Exercise/Conversion
Restricted Stock Units
2022-05-01−5,623→ 16,871 total→ Common Stock (5,623 underlying) - Exercise/Conversion
Common Stock
2022-05-01+5,623→ 87,947 total - Sale
Common Stock
2022-05-02$1.97/sh−2,508$4,940→ 85,439 total - Exercise/Conversion
Common Stock
2022-05-01+4,625→ 90,064 total - Sale
Common Stock
2022-05-02$1.97/sh−2,062$4,062→ 88,002 total
Footnotes (5)
- [F1]Each Restricted Stock Unit represents the right to receive one share of Common Stock.
- [F2]Represents the shares automatically sold by the reporting person pursuant to an election to satisfy tax withholding obligations in connection with the vesting of the Restricted Stock Units listed in Table II. This sale does not represent a discretionary trade by the reporting person.
- [F3]This transaction was executed in multiple trades at prices ranging from $1.9515 to $1.9700. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]On February 1, 2019, the reporting person was granted 89,982 Restricted Stock Units. 25% of such Restricted Stock Units vested on February 1, 2020, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date.
- [F5]On January 31, 2020, the reporting person was granted 74,000 Restricted Stock Units. 25% of such Restricted Stock Units vested on February 1, 2021, and the remainder vests in substantially equal installments over the 12 quarters immediately following such date.
Documents
Issuer
Clovis Oncology, Inc.
CIK 0001466301
Entity typeother
Related Parties
1- filerCIK 0001283569
Filing Metadata
- Form type
- 4
- Filed
- May 2, 8:00 PM ET
- Accepted
- May 3, 4:15 PM ET
- Size
- 15.2 KB